Elesclomol Research

Individuals with defects in copper metabolism may soon have more targeted treatment options thanks to a discovery by a research team led by Dr. Vishal Gohil of Texas A&M AgriLife Research in College Station.
A paper in the Proceedings of the National Academy of Sciences at http://www.pnas.org/content/early/2018/07/17/1806296115 reports that an investigational anticancer-drug, elesclomol, can restore the production of cytochrome oxidase protein complex, a critical copper-dependent enzyme required for mitochondrial energy production.

Видео Elesclomol Research канала AgriLife Today - Texas Agriculture News